Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
J Urol. 2017 Sep;198(3):671-677. doi: 10.1016/j.juro.2017.03.121. Epub 2017 Mar 22.
Comparing patient reported outcomes such as urinary and erectile function across institutions is critical for prostate cancer research and quality assurance. Such comparisons are complicated due to the use of different questionnaires. We aimed to develop a method to convert scores among 4 commonly used instruments.
Patient reported data on urinary and sexual function were collected on 1,284 men with localized prostate cancer using the EPIC-26 (Expanded Prostate Index Composite), PCI (UCLA Prostate Cancer Index), SHIM (Sexual Health Inventory for Men) and I-PSS (International Prostate Symptom Scale) questionnaires. We investigated several methods to convert scores among questionnaires.
Conversion between EPIC and PCI urinary and sexual function subscales was best achieved using only the subset of questions asked on both questionnaires. For the conversion between EPIC or PCI erectile function scores and SHIM scores, we defined thresholds of poor, intermediate and good function as EPIC/PCI 0 to 40 and SHIM 1 to 7, EPIC/PCI 41 to 59 and SHIM 8 to 16, and EPIC/PCI 60 to 100 and SHIM 17 to 25, respectively. Urinary continence scores highly correlated for PCI and EPIC (r = 0.94). No comparison was possible for I-PSS with EPIC and PCI due to differences in the domains addressed by these questionnaires.
We have introduced methods to convert scores among the EPIC, PCI and SHIM questionnaires. While these conversion methods may introduce minor imprecision, to our knowledge they represent the best available tools to combine and compare patient reported outcomes that are assessed using different instruments in men undergoing radical prostatectomy or active surveillance.
比较患者报告的结果,如尿和性功能,对于前列腺癌的研究和质量保证至关重要。由于使用不同的问卷,这种比较很复杂。我们的目的是开发一种方法来转换 4 种常用仪器的评分。
采用 EPIC-26(扩展前列腺指数综合)、PCI(加州大学洛杉矶分校前列腺癌指数)、SHIM(男性性健康问卷)和 I-PSS(国际前列腺症状评分)问卷,对 1284 名局限性前列腺癌患者的尿和性功能进行了患者报告数据收集。我们研究了几种方法来转换问卷之间的分数。
EPIC 和 PCI 尿和性功能子量表之间的转换最好仅使用两个问卷中都问到的问题子集来实现。对于 EPIC 或 PCI 勃起功能评分与 SHIM 评分之间的转换,我们将 EPIC/PCI0 至 40 和 SHIM1 至 7 定义为功能差、功能中等和功能良好的阈值,EPIC/PCI41 至 59 和 SHIM8 至 16,EPIC/PCI60 至 100 和 SHIM17 至 25。PCI 和 EPIC 的尿控评分高度相关(r=0.94)。由于这些问卷所涉及的领域不同,因此无法对 I-PSS 与 EPIC 和 PCI 进行比较。
我们已经提出了一种方法来转换 EPIC、PCI 和 SHIM 问卷的评分。虽然这些转换方法可能会引入一些不精确,但据我们所知,它们是在接受根治性前列腺切除术或主动监测的男性中,结合和比较使用不同仪器评估的患者报告结果的最佳工具。